NASDAQ:ESRX - Express Scripts Stock Price, Price Target & More

$76.71 +0.19 (+0.25 %)
(As of 04/26/2018 04:00 PM ET)
Previous Close$76.71
Today's Range$76.0910 - $77.33
52-Week Range$55.80 - $85.07
Volume2.44 million shs
Average Volume4.96 million shs
Market Capitalization$42.39 billion
P/E Ratio10.80
Dividend YieldN/A
Beta0.99

About Express Scripts (NASDAQ:ESRX)

Express Scripts logoExpress Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services. This segment also provides Medicare, Medicaid, and health insurance marketplace products; Express Scripts SafeGuardRx, a suite of solutions targeting the therapy classes that pose clinical challenges and budgetary threat to its clients; and Inside Rx, a program that provide affordable access to medication for uninsured and underinsured individuals. Its Other Business Operations segment distributes specialty pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides medical benefit management solutions for radiology, cardiology, musculoskeletal disorders, sleep disorders, post-acute care, genetic lab, specialty pharmacy, and medical oncology. The company serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, providers, clinics, hospitals, and others. As of December 31, 2017, it operated 4 automated dispensing home delivery pharmacies; 1 non-automated dispensing home delivery pharmacy; 7 non-dispensing order processing centers; 5 patient contact centers; 9 specialty home delivery pharmacies; and 34 specialty branch pharmacies. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in Saint Louis, Missouri.

Receive ESRX News and Ratings via Email

Sign-up to receive the latest news and ratings for ESRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryHealth Care Services
SectorMedical
SymbolNASDAQ:ESRX
CUSIP30219G10
Phone314-996-0900

Debt

Debt-to-Equity Ratio0.83%
Current Ratio0.67%
Quick Ratio0.55%

Price-To-Earnings

Trailing P/E Ratio10.80
Forward P/E Ratio8.23
P/E Growth0.93

Sales & Book Value

Annual Sales$100.06 billion
Price / Sales0.43
Cash Flow$10.6542 per share
Price / Cash7.20
Book Value$32.00 per share
Price / Book2.40

Profitability

EPS (Most Recent Fiscal Year)$7.10
Net Income$4.52 billion
Net Margins4.51%
Return on Equity25.19%
Return on Assets8.00%

Miscellaneous

Employees26,600
Outstanding Shares561,530,000

Express Scripts (NASDAQ:ESRX) Frequently Asked Questions

What is Express Scripts' stock symbol?

Express Scripts trades on the NASDAQ under the ticker symbol "ESRX."

How will Express Scripts' stock buyback program work?

Express Scripts declared that its Board of Directors has approved a share repurchase plan on Wednesday, December 20th 2017, which permits the company to buyback 45,000,000 shares, according to EventVestor. This buyback authorization permits the company to repurchase shares of its stock through open market purchases. Stock buyback plans are often a sign that the company's board of directors believes its stock is undervalued.

How were Express Scripts' earnings last quarter?

Express Scripts (NASDAQ:ESRX) released its quarterly earnings results on Tuesday, February, 27th. The company reported $2.16 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $2.09 by $0.07. The company had revenue of $25.38 billion for the quarter, compared to the consensus estimate of $25.07 billion. Express Scripts had a net margin of 4.51% and a return on equity of 25.19%. The business's revenue was up 2.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.88 EPS. View Express Scripts' Earnings History.

When is Express Scripts' next earnings date?

Express Scripts is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for Express Scripts.

What guidance has Express Scripts issued on next quarter's earnings?

Express Scripts issued an update on its FY18 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of $9.27-9.47 for the period, compared to the Thomson Reuters consensus EPS estimate of $8.93. Express Scripts also updated its Q1 guidance to $1.73-1.78 EPS.

What price target have analysts set for ESRX?

19 brokerages have issued 1 year price objectives for Express Scripts' stock. Their forecasts range from $57.00 to $101.00. On average, they expect Express Scripts' stock price to reach $82.6538 in the next twelve months. View Analyst Ratings for Express Scripts.

What are Wall Street analysts saying about Express Scripts stock?

Here are some recent quotes from research analysts about Express Scripts stock:
  • 1. According to Zacks Investment Research, "Integrating medical care and pharmacy benefits under one roof, Express Scripts Holding Company recently announced that it is getting acquired by Cigna Corporation, a global health insurance company.The company has been benefitting from a rise in patient claims and strong customer retention. Express Scripts’ solid guidance for 2018 holds promise. The company recently inked an agreement to acquire eviCore healthcare for $3.6 billion. Express Scripts' pharmacy-benefit management segment (PBM) coupled with eviCore's complementary medical-benefit solutions is likely to build a comprehensive PBM solution worldwide. On the flip side, the company recently announced that its biggest customer and leading health insurer Anthem is not likely to extend its PBM agreement with Express Scripts anymore. Persistent drug pricing issue is also anticipated to affect the stock. The company faces stiff competition." (3/13/2018)
  • 2. Maxim Group analysts commented, "Cigna Corp (CI – NR) agreed to acquire ESRX for $54B, with per-share consideration of $48.75 in cash and 0.2434 shares of CI stock. CI also agreed to assume roughly $13B of net debt from ESRX." (3/8/2018)

Are investors shorting Express Scripts?

Express Scripts saw a decline in short interest in March. As of March 15th, there was short interest totalling 19,241,219 shares, a decline of 20.8% from the February 28th total of 24,284,790 shares. Based on an average trading volume of 8,958,251 shares, the days-to-cover ratio is currently 2.1 days. Approximately 3.4% of the company's stock are short sold.

Who are some of Express Scripts' key competitors?

Who are Express Scripts' key executives?

Express Scripts' management team includes the folowing people:
  • Mr. Timothy C. Wentworth, CEO, Pres & Director (Age 58)
  • Mr. Neal Sample, Exec. VP & COO (Age 43)
  • Mr. David A. Queller, Sr. VP of Sales & Account Management (Age 49)
  • Ms. Christine Houston, Exec. VP (Age 55)
  • Mr. Eric R. Slusser, Exec. Officer (Age 57)

Has Express Scripts been receiving favorable news coverage?

Media headlines about ESRX stock have been trending somewhat positive on Thursday, Accern Sentiment Analysis reports. The research group rates the sentiment of news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Express Scripts earned a media sentiment score of 0.12 on Accern's scale. They also assigned news headlines about the company an impact score of 47.11 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future.

How do I buy shares of Express Scripts?

Shares of ESRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Express Scripts' stock price today?

One share of ESRX stock can currently be purchased for approximately $76.71.

How big of a company is Express Scripts?

Express Scripts has a market capitalization of $42.39 billion and generates $100.06 billion in revenue each year. The company earns $4.52 billion in net income (profit) each year or $7.10 on an earnings per share basis. Express Scripts employs 26,600 workers across the globe.

How can I contact Express Scripts?

Express Scripts' mailing address is ONE EXPRESS WAY, ST. LOUIS MO, 63121. The company can be reached via phone at 314-996-0900 or via email at [email protected]


MarketBeat Community Rating for Express Scripts (ESRX)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  697 (Vote Outperform)
Underperform Votes:  485 (Vote Underperform)
Total Votes:  1,182
MarketBeat's community ratings are surveys of what our community members think about Express Scripts and other stocks. Vote "Outperform" if you believe ESRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ESRX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Express Scripts (NASDAQ:ESRX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
19 Wall Street analysts have issued ratings and price targets for Express Scripts in the last 12 months. Their average twelve-month price target is $82.6538, suggesting that the stock has a possible upside of 7.75%. The high price target for ESRX is $101.00 and the low price target for ESRX is $57.00. There are currently 3 sell ratings, 11 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.112.102.142.00
Ratings Breakdown: 3 Sell Rating(s)
11 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
12 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
4 Sell Rating(s)
10 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
5 Sell Rating(s)
11 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $82.6538$81.8214$79.2143$69.2308
Price Target Upside: 7.75% upside1.33% upside2.39% downside13.20% upside

Express Scripts (NASDAQ:ESRX) Consensus Price Target History

Price Target History for Express Scripts (NASDAQ:ESRX)

Express Scripts (NASDAQ:ESRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/12/2018Sanford C. BernsteinUpgradeUnderperform -> Market PerformMediumView Rating Details
3/9/2018Wells FargoUpgradeUnderperform -> Market PerformLowView Rating Details
3/8/2018Raymond JamesUpgradeUnderperform -> Market PerformLowView Rating Details
3/8/2018MizuhoSet Price TargetHold$96.00LowView Rating Details
3/8/2018William BlairDowngradeOutperform -> Market PerformLowView Rating Details
3/8/2018Jefferies GroupDowngradeBuy -> Hold$91.00HighView Rating Details
3/8/2018Maxim GroupDowngradeBuy -> HoldHighView Rating Details
3/8/2018BarclaysInitiated CoverageEqual Weight -> Equal Weight$84.00HighView Rating Details
2/27/2018Bank of AmericaInitiated CoverageUnderperform -> Underperform$77.00MediumView Rating Details
1/31/2018Royal Bank of CanadaUpgradeSector Perform -> Outperform$68.00LowView Rating Details
1/12/2018SunTrust BanksReiterated RatingBuy$95.00LowView Rating Details
1/9/2018Robert W. BairdReiterated RatingOutperform -> Buy$81.00 -> $92.00N/AView Rating Details
1/4/2018Evercore ISIInitiated CoverageIn -> In-Line$78.00LowView Rating Details
12/21/2017Needham & Company LLCReiterated RatingHoldLowView Rating Details
12/4/2017Deutsche BankInitiated CoverageBuy$75.00HighView Rating Details
10/9/2017UBSDowngradeMarket Perform -> UnderperformN/AView Rating Details
8/10/2017Morgan StanleyBoost Price TargetUnderweight$52.00 -> $57.00LowView Rating Details
6/9/2017CowenReiterated RatingOutperform$83.00LowView Rating Details
4/26/2017Edward JonesDowngradeBuy -> HoldHighView Rating Details
3/29/2017ArgusReiterated RatingHoldLowView Rating Details
3/8/2017Leerink SwannReiterated RatingMarket Perform$75.00LowView Rating Details
2/16/2017Credit Suisse GroupReiterated RatingBuy$85.00N/AView Rating Details
2/14/2017OppenheimerReiterated RatingHoldN/AView Rating Details
6/1/2016WedbushReiterated RatingNeutralN/AView Rating Details
5/24/2016CitigroupReiterated RatingBuyN/AView Rating Details
4/27/2016FBR & CoLower Price TargetMkt Perform$90.00 -> $75.00N/AView Rating Details
(Data available from 4/26/2016 forward)

Earnings

Express Scripts (NASDAQ:ESRX) Earnings History and Estimates Chart

Earnings by Quarter for Express Scripts (NASDAQ:ESRX)

Express Scripts (NASDAQ:ESRX) Earnings Estimates

2018 EPS Consensus Estimate: $9.06
2019 EPS Consensus Estimate: $9.65
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20185$1.46$1.76$1.69
Q2 20185$1.90$2.39$2.22
Q3 20185$2.09$2.57$2.43
Q4 20185$2.31$2.88$2.71
Q1 20193$1.58$2.10$1.87
Q2 20193$2.09$2.48$2.32
Q3 20193$2.26$2.67$2.53
Q4 20192$2.88$2.97$2.93

Express Scripts (NASDAQ ESRX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018$1.76N/AView Earnings Details
2/27/2018Q4 2017$2.09$2.16$25.0710 billion$25.3790 billionViewN/AView Earnings Details
10/24/2017Q3 2017$1.90$1.90$25.6827 billion$24.6834 billionViewN/AView Earnings Details
7/25/2017Q2 2017$1.71$1.73$25.5249 billion$25.3475 billionViewN/AView Earnings Details
4/24/2017Q1 17$1.32$1.33$24.9516 billion$24.6549 billionViewN/AView Earnings Details
2/14/2017Q4 2016$1.8660$1.88$26.31 billion$24.90 billionViewListenView Earnings Details
10/25/2016Q3$1.74$1.74$25.4846 billion$25.41 billionViewListenView Earnings Details
7/25/2016Q216$1.57$1.57$25.42 billion$25.20 billionViewListenView Earnings Details
4/25/2016Q1$1.22$1.22$25.20 billion$24.80 billionViewListenView Earnings Details
2/16/2016Q4$1.56$1.56$26.58 billion$26.18 billionViewListenView Earnings Details
10/27/2015Q315$1.44$1.45$26.38 million$25.22 millionViewListenView Earnings Details
7/28/2015Q215$1.40$1.44$26.13 billion$25.4540 billionViewListenView Earnings Details
4/28/2015Q115$1.10$1.10$24.34 billion$24.90 billionViewListenView Earnings Details
2/23/2015Q414$1.38$1.39$25.68 billion$26.31 billionViewListenView Earnings Details
10/28/2014Q314$1.29$1.29$24.93 billion$25.78 billionViewListenView Earnings Details
7/29/2014Q214$1.22$1.23$24.42 billion$25.1110 billionViewListenView Earnings Details
4/29/2014Q114$1.01$0.99$23.81 billion$23.6850 billionViewListenView Earnings Details
2/20/2014Q413$1.12$1.12$25.49 billion$25.78 billionViewN/AView Earnings Details
10/25/2013Q313$1.08$1.08$25.01 billion$25.9160 billionViewListenView Earnings Details
7/29/2013Q2 2013$1.10$1.12$25.51 billion$26.40 billionViewListenView Earnings Details
4/29/2013Q1 2013$0.97$0.99$25.55 billion$26.0630 billionViewListenView Earnings Details
2/18/2013Q4 2012$1.04$1.05$27.24 billion$27.41 billionViewListenView Earnings Details
11/5/2012Q312$0.99$1.02$27.48 billion$27.00 billionViewN/AView Earnings Details
8/7/2012$0.82$0.88ViewN/AView Earnings Details
5/10/2012$0.77$0.73ViewN/AView Earnings Details
2/22/2012$0.85$0.82ViewN/AView Earnings Details
10/25/2011$0.77$0.79ViewN/AView Earnings Details
7/21/2011$0.69$0.71ViewN/AView Earnings Details
4/26/2011$0.69$0.66ViewN/AView Earnings Details
2/16/2011$0.70$0.71ViewN/AView Earnings Details
10/27/2010Q3 2010$0.65$0.65ViewN/AView Earnings Details
7/28/2010Q2 2010$0.59$0.60ViewN/AView Earnings Details
4/28/2010Q1 2010$0.55$0.55ViewN/AView Earnings Details
2/24/2010Q4 2009$0.45$0.49ViewN/AView Earnings Details
10/28/2009Q3 2009$0.41$0.40ViewN/AView Earnings Details
7/29/2009Q2 2009$0.44$0.44ViewN/AView Earnings Details
4/29/2009Q1 2009$0.41$0.43ViewN/AView Earnings Details
2/25/2009Q4 2008$0.42$0.41ViewN/AView Earnings Details
10/30/2008Q3 2008$0.39$0.41ViewN/AView Earnings Details
7/30/2008Q2 2008$0.36$0.38ViewN/AView Earnings Details
4/29/2008Q1 2008$0.34$0.35ViewN/AView Earnings Details
2/21/2008Q4 2007$0.32$0.34ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Express Scripts (NASDAQ:ESRX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Express Scripts (NASDAQ ESRX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.79%
Institutional Ownership Percentage: 89.29%
Insider Trading History for Express Scripts (NASDAQ:ESRX)
Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Express Scripts (NASDAQ ESRX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/15/2018Christine HoustonInsiderSell19,889$76.69$1,525,287.41View SEC Filing  
3/1/2018Everett NevilleVPSell4,895$75.26$368,397.70View SEC Filing  
1/11/2018Glen D StettinVPSell3,449$81.00$279,369.0033,715View SEC Filing  
1/2/2018Glen D StettinVPSell3,448$76.00$262,048.00View SEC Filing  
12/15/2017Christine HoustonVPSell10,104$70.08$708,088.3287,400View SEC Filing  
11/1/2017Phyllis S. AndersonVPSell643$62.37$40,103.91View SEC Filing  
10/31/2017Timothy C WentworthCEOBuy8,000$61.13$489,040.0098,628View SEC Filing  
9/11/2017Woodrow A Myers JrDirectorSell3,900$63.93$249,327.0011,500View SEC Filing  
9/8/2017Phyllis S AndersonVPSell578$63.13$36,489.1410,530View SEC Filing  
8/23/2017Everett NevilleVPSell1,163$61.48$71,501.2418,232View SEC Filing  
5/19/2017Phyllis S AndersonVPSell1,100$60.08$66,088.0011,108View SEC Filing  
3/1/2017Everett NevilleSVPSell2,352$70.16$165,016.3211,287View SEC Filing  
1/3/2017Everett NevilleVPSell1,123$69.41$77,947.4312,712View SEC Filing  
9/14/2016Woodrow A Myers JrDirectorSell12,036$70.40$847,334.4014,918View SEC Filing  
9/12/2016Christopher A McginnisVPSell1,785$70.77$126,324.454,955View SEC Filing  
5/10/2016Everett NevilleVPSell800$74.11$59,288.0013,835View SEC Filing  
4/29/2016Mahon Thomas P MacDirectorSell5,482$73.93$405,284.2655,689View SEC Filing  
3/10/2016Christopher A McginnisVPSell579$68.56$39,696.246,508View SEC Filing  
3/7/2016Phyllis S AndersonVPSell614$71.14$43,679.964,346View SEC Filing  
2/29/2016Everett NevilleVPSell4,323$71.00$306,933.0011,126View SEC Filing  
6/9/2015Gary WimberlyVPSell1,644$87.14$143,258.16View SEC Filing  
6/1/2015Gary WimberlyVPSell46,069$86.15$3,968,844.35View SEC Filing  
3/2/2015Glen D StettinVPSell2,674$84.39$225,658.86View SEC Filing  
2/25/2015Glen D StettinVPSell27,603$87.55$2,416,642.65View SEC Filing  
12/2/2014Keith J EblingVPSell10,000$84.25$842,500.00View SEC Filing  
12/1/2014Steven B MillerVPSell4,896$83.57$409,158.72View SEC Filing  
11/28/2014Glen D StettinVPSell10,800$82.96$895,968.00View SEC Filing  
11/17/2014John O ParkerDirectorSell25,822$78.75$2,033,482.50View SEC Filing  
11/7/2014Maura C BreenDirectorSell13,128$77.80$1,021,358.40View SEC Filing  
9/5/2014Edward B IgnaczakEVPSell9,886$75.28$744,218.08View SEC Filing  
8/28/2014Seymour SternbergDirectorSell15,508$74.12$1,149,452.96View SEC Filing  
8/25/2014Keith J EblingVPSell10,000$75.50$755,000.00View SEC Filing  
8/5/2014Gary G BenanavDirectorSell12,694$70.82$898,989.08View SEC Filing  
8/5/2014Sara E WadeVPSell20,000$70.44$1,408,800.00View SEC Filing  
8/4/2014David A NortonVPSell1,276$71.02$90,621.52View SEC Filing  
8/1/2014Maura C BreenDirectorSell12,694$69.94$887,818.36View SEC Filing  
6/13/2014George PazCEOSell681,508$71.21$48,530,184.68View SEC Filing  
3/11/2014Keith EblingVPSell25,721$78.69$2,023,985.4922,222View SEC Filing  
3/10/2014Patrick McnameeCOOSell68,425$78.28$5,356,309.0012,421View SEC Filing  
3/10/2014Steven MillerVPSell12,664$77.96$987,285.4421,417View SEC Filing  
3/7/2014Keith EblingVPSell295,367$77.29$22,828,915.4328,460View SEC Filing  
1/9/2014Nicholas LahowchicDirectorSell7,650$72.00$550,800.0024,903View SEC Filing  
12/26/2013Nicholas LahowchicDirectorSell12,694$70.00$888,580.0024,903View SEC Filing  
11/5/2013Mahon Thomas MacDirectorSell10,251$63.20$647,863.2039,881View SEC Filing  
9/9/2013Maura C BreenDirectorSell10,527$64.12$674,991.24View SEC Filing  
9/4/2013Woodrow Myers, Jr.DirectorSell7,128$64.66$460,896.489,698View SEC Filing  
7/19/2013Nicholas LahowchicDirectorSell20,377$66.26$1,350,180.02View SEC Filing  
6/11/2013Woodrow A Myers JrDirectorSell1,750$62.57$109,497.50View SEC Filing  
5/28/2013Woodrow A Myers JrDirectorSell2,000$63.75$127,500.00View SEC Filing  
5/15/2013Jeffrey HallCFOSell13,307$61.13$813,456.91View SEC Filing  
5/8/2013Woodrow A Myers JrDirectorSell13,462$61.22$824,143.64View SEC Filing  
5/1/2013Keith J EblingEVPSell59,494$59.58$3,544,652.52View SEC Filing  
4/30/2013Patrick McnameeCOOSell271,972$59.65$16,223,129.80View SEC Filing  
3/14/2013Mahon Thomas P MacDirectorBuy5,000$59.58$297,900.00View SEC Filing  
9/4/2012Jeffrey HallCFOSell75,000$62.81$4,710,750.00View SEC Filing  
8/8/2012Edward B IgnaczakEVPSell115,466$59.33$6,850,597.78View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Express Scripts (NASDAQ ESRX) News Headlines

Source:
DateHeadline
ValuEngine Upgrades Express Scripts (ESRX) to BuyValuEngine Upgrades Express Scripts (ESRX) to Buy
www.americanbankingnews.com - April 26 at 2:04 PM
Express Scripts (ESRX) Lifted to "Buy" at BidaskClubExpress Scripts (ESRX) Lifted to "Buy" at BidaskClub
www.americanbankingnews.com - April 26 at 1:05 PM
Interesting ESRX Put And Call Options For July 20thInteresting ESRX Put And Call Options For July 20th
www.nasdaq.com - April 25 at 5:44 PM
Express Scripts (ESRX) to Release Earnings on WednesdayExpress Scripts (ESRX) to Release Earnings on Wednesday
www.americanbankingnews.com - April 25 at 8:48 AM
"Knowing But Not Doing: The State of Rx Adherence in America Report" Finds Big Difference in What Americans Know and Do When It Comes to Their Chronic Medications"Knowing But Not Doing: The State of Rx Adherence in America Report" Finds Big Difference in What Americans Know and Do When It Comes to Their Chronic Medications
finance.yahoo.com - April 25 at 8:00 AM
Can PBM Unit Boost Express Scripts (ESRX) Q1 Earnings?Can PBM Unit Boost Express Scripts' (ESRX) Q1 Earnings?
www.zacks.com - April 24 at 8:02 AM
DoJ asks Cigna, Express Scripts for additional informationDoJ asks Cigna, Express Scripts for additional information
finance.yahoo.com - April 23 at 5:25 PM
Fight against opioids impacts workers' comp spending, myMatrixx report findsFight against opioids impacts workers' comp spending, myMatrixx report finds
finance.yahoo.com - April 23 at 8:01 AM
Express Scripts (ESRX) Downgraded by BidaskClub to SellExpress Scripts (ESRX) Downgraded by BidaskClub to Sell
www.americanbankingnews.com - April 19 at 11:34 AM
Cigna-Express Scripts Deal to Face Justice Department ReviewCigna-Express Scripts Deal to Face Justice Department Review
finance.yahoo.com - April 19 at 8:05 AM
How Is UNH’s Optum Business Positioned in the Industry?How Is UNH’s Optum Business Positioned in the Industry?
finance.yahoo.com - April 17 at 8:03 AM
Express Scripts (ESRX) Expected to Announce Quarterly Sales of $24.76 BillionExpress Scripts (ESRX) Expected to Announce Quarterly Sales of $24.76 Billion
www.americanbankingnews.com - April 16 at 4:00 AM
Express Scripts (ESRX) Scheduled to Post Earnings on MondayExpress Scripts (ESRX) Scheduled to Post Earnings on Monday
www.americanbankingnews.com - April 16 at 3:46 AM
 Brokerages Expect Express Scripts (ESRX) Will Post Earnings of $1.76 Per Share Brokerages Expect Express Scripts (ESRX) Will Post Earnings of $1.76 Per Share
www.americanbankingnews.com - April 14 at 9:19 AM
Express Scripts Holding Company Announces First Quarter 2018 Earnings Release DetailsExpress Scripts Holding Company Announces First Quarter 2018 Earnings Release Details
feeds.benzinga.com - April 13 at 3:36 PM
Express Scripts launches innovative pilot program for performance-based retail pharmacy networkExpress Scripts launches innovative pilot program for performance-based retail pharmacy network
seekingalpha.com - April 12 at 5:59 PM
Is Express Scripts Holding Company’s (NASDAQ:ESRX) Balance Sheet Strong Enough To Weather A Storm?Is Express Scripts Holding Company’s (NASDAQ:ESRX) Balance Sheet Strong Enough To Weather A Storm?
finance.yahoo.com - April 12 at 5:59 PM
Head to Head Survey: Express Scripts (ESRX) and HealthWarehouse.com (HEWA)Head to Head Survey: Express Scripts (ESRX) and HealthWarehouse.com (HEWA)
www.americanbankingnews.com - April 12 at 9:33 AM
Express Scripts to close Ohio site, lay off 456Express Scripts to close Ohio site, lay off 456
www.bizjournals.com - April 11 at 5:54 PM
Express Scripts to close Columbus site, lay off 456Express Scripts to close Columbus site, lay off 456
www.bizjournals.com - April 10 at 5:46 PM
Profit From Record Q1 M&A With These ETFsProfit From Record Q1 M&A With These ETFs
finance.yahoo.com - April 10 at 5:46 PM
U.S. Workers Compensation Prescription Drug Spending Decreased 3.3 Percent in 2017U.S. Workers' Compensation Prescription Drug Spending Decreased 3.3 Percent in 2017
finance.yahoo.com - April 10 at 8:04 AM
Express Scripts (ESRX) Upgraded by ValuEngine to BuyExpress Scripts (ESRX) Upgraded by ValuEngine to Buy
www.americanbankingnews.com - April 8 at 12:54 PM
Robert W. Baird Boosts Express Scripts (ESRX) Price Target to $59.00Robert W. Baird Boosts Express Scripts (ESRX) Price Target to $59.00
www.americanbankingnews.com - April 5 at 2:27 PM
Express Scripts (ESRX) Given Consensus Recommendation of "Hold" by BrokeragesExpress Scripts (ESRX) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - April 5 at 12:10 PM
Analyzing Walgreens Boots Alliance (WBA) & Express Scripts (ESRX)Analyzing Walgreens Boots Alliance (WBA) & Express Scripts (ESRX)
www.americanbankingnews.com - April 5 at 9:31 AM
Royal Bank of Canada Analysts Give Express Scripts (ESRX) a $66.00 Price TargetRoyal Bank of Canada Analysts Give Express Scripts (ESRX) a $66.00 Price Target
www.americanbankingnews.com - April 4 at 9:36 PM
Express Scripts Appoints New CIO from Farmers InsuranceExpress Scripts Appoints New CIO from Farmers Insurance
finance.yahoo.com - April 4 at 4:30 PM
Ohio regulator orders insurers, benefit managers to give lowest drug priceOhio regulator orders insurers, benefit managers to give lowest drug price
finance.yahoo.com - April 4 at 4:30 PM
Head to Head Contrast: Walgreens Boots Alliance (WBA) & Express Scripts (ESRX)Head to Head Contrast: Walgreens Boots Alliance (WBA) & Express Scripts (ESRX)
www.americanbankingnews.com - April 4 at 3:38 PM
Express Scripts Names Ron Guerrier Chief Information OfficerExpress Scripts Names Ron Guerrier Chief Information Officer
finance.yahoo.com - April 3 at 5:49 PM
Express Scripts (ESRX) Downgraded by ValuEngine to "Hold"Express Scripts (ESRX) Downgraded by ValuEngine to "Hold"
www.americanbankingnews.com - April 3 at 4:16 PM
Critical Comparison: Express Scripts (ESRX) & Rite Aid (RAD)Critical Comparison: Express Scripts (ESRX) & Rite Aid (RAD)
www.americanbankingnews.com - April 3 at 1:42 PM
Express Scripts Names Mike Cirillo President of myMatrixxExpress Scripts Names Mike Cirillo President of myMatrixx
finance.yahoo.com - April 2 at 5:42 PM
Q1 Witnesses Consolidation Wave With All-Time High Global M&AQ1 Witnesses Consolidation Wave With All-Time High Global M&A
finance.yahoo.com - April 2 at 8:00 AM
MARKETS: FANG stocks and chipmakers are set to close Q1 with a bang—maybe even AMZNMARKETS: FANG stocks and chipmakers are set to close Q1 with a bang—maybe even AMZN
finance.yahoo.com - March 31 at 5:44 PM
Express Scripts Holding (ESRX) Expected to Announce Quarterly Sales of $24.76 BillionExpress Scripts Holding (ESRX) Expected to Announce Quarterly Sales of $24.76 Billion
www.americanbankingnews.com - March 30 at 3:04 AM
Express Scripts (ESRX) Rating Reiterated by Robert W. BairdExpress Scripts (ESRX) Rating Reiterated by Robert W. Baird
www.americanbankingnews.com - March 30 at 12:56 AM
Why Is Express Scripts Holding Company (ESRX) Down 10.5% Since its Last Earnings Report?Why Is Express Scripts Holding Company (ESRX) Down 10.5% Since its Last Earnings Report?
finance.yahoo.com - March 29 at 5:44 PM
Short Interest in Express Scripts Holding (ESRX) Drops By 20.8%Short Interest in Express Scripts Holding (ESRX) Drops By 20.8%
www.americanbankingnews.com - March 29 at 3:10 AM
Why Express Scripts Stock Could Improve From HereWhy Express Scripts Stock Could Improve From Here
finance.yahoo.com - March 28 at 5:35 PM
CareCentrix, Inc. -- Moodys affirms CareCentrixs B1 ratings; changes outlook to stableCareCentrix, Inc. -- Moody's affirms CareCentrix's B1 ratings; changes outlook to stable
finance.yahoo.com - March 28 at 5:35 PM
$1.77 EPS Expected for Express Scripts Holding (ESRX) This Quarter$1.77 EPS Expected for Express Scripts Holding (ESRX) This Quarter
www.americanbankingnews.com - March 28 at 9:16 AM
Is Express Scripts Holding Company (NASDAQ:ESRX) A Buy At Its Current PE Ratio?Is Express Scripts Holding Company (NASDAQ:ESRX) A Buy At Its Current PE Ratio?
finance.yahoo.com - March 28 at 8:06 AM
Here’s the Truth About Express Scripts Holding Co Stock and PBMsHere’s the Truth About Express Scripts Holding Co Stock and PBMs
investorplace.com - March 28 at 7:16 AM
Pre-Market Technical Scan on Health Care Plans Equities -- Centene, Cigna, CVS Health, and Express ScriptsPre-Market Technical Scan on Health Care Plans Equities -- Centene, Cigna, CVS Health, and Express Scripts
www.prnewswire.com - March 27 at 8:04 AM
Cigna (CI) to Acquire Express Scripts (ESRX) for $67 BillionCigna (CI) to Acquire Express Scripts (ESRX) for $67 Billion
www.streetinsider.com - March 26 at 5:36 PM
Express Scripts (ESRX) Upgraded to Outperform at Royal Bank of CanadaExpress Scripts (ESRX) Upgraded to Outperform at Royal Bank of Canada
www.americanbankingnews.com - March 26 at 11:34 AM
Express Scripts (ESRX) Receives New Coverage from Analysts at Bank of AmericaExpress Scripts (ESRX) Receives New Coverage from Analysts at Bank of America
www.americanbankingnews.com - March 24 at 9:28 PM
Express Scripts (ESRX) PT Set at $91.00 by Jefferies GroupExpress Scripts (ESRX) PT Set at $91.00 by Jefferies Group
www.americanbankingnews.com - March 24 at 5:46 PM

SEC Filings

Express Scripts (NASDAQ:ESRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Express Scripts (NASDAQ:ESRX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Express Scripts (NASDAQ ESRX) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.